Table 6 Results of multivariate regression analysis for BCVA at 12 months as dependent variables.

From: Morphological parameters of myopic choroidal neovascularization as predictive factors of anti-VEGF treatment response

 

Beta

p

Baseline parameters

BCVA

0.773

 < 0.001

Immature mCNV pattern

− 0.237

0.005

1-month parameters

BCVA

0.826

 < 0.001

6-month parameters

BCVA

0.943

 < 0.001

12-month parameters

mCNV area at M12

0.490

0.001

  1. BCVA Best-Corrected Visual Acuity, mCNV myopic choroidal neovascularization, M1 1-month examination, M6 6-month examination, M12 12-month examination.